
79.82 Delayed Data As of Dec 01 | ![]() Today’s Change | 62.55 Today|||52-Week Range 217.25 | -55.56% Year-to-Date |
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use Nov 29 / Zacks.com - Paid Partner Content | 3 Biotech Stocks That Could Be Millionaire Makers Nov 22 / MotleyFool.com - Paid Partner Content |
Arcturus' (ARCT) CF Drug Gets FDA's Orphan Status, Stock Up Nov 28 / Zacks.com - Paid Partner Content | Vertex (VRTX) Non-Cystic Fibrosis Pipeline Boosts Stock This Year Nov 21 / Zacks.com - Paid Partner Content |
Moderna (MRNA): A Fair Valuation in Today's Market? Nov 28 / GuruFocus News - Paid Partner Content |
Previous close | 77.70 |
Today’s open | 76.50 |
Day’s range | 74.52 - 80.26 |
Volume | 235,583 |
Average volume (3 months) | 4,125,957 |
Market cap | $30.4B |
Earnings growth (last year) | -29.90% |
Earnings growth (this year) | -112.01% |
Earnings growth (next 5 years) | -51.00% |
Revenue growth (last year) | +3.78% |
P/E ratio | NM |
Price/Sales | 3.91 |
Price/Book | 1.61 |
Today’s change | Today’s % change | |
---|---|---|
BIIBBiogen | +0.53 | +0.23% |
---- | ||
BMRNBiomarin Pharmaceuti... | +1.37 | +1.50% |
ILMNIllumina Inc | +7.85 | +7.70% |
Next reporting date | February 22, 2024 |
EPS forecast (this quarter) | $0.97 |
Annual revenue (last year) | $19.1B |
Annual profit (last year) | $8.4B |
Net profit margin | 43.76% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |